• Acumen Pharmaceuticals and Unlearn Collaborate to Explore Analyses of Alzheimer's Disease Clinical Programs Rutland Herald Thu, 09 Jul 2026 10:02:16 GMT
• Acumen Pharmaceuticals (ABOS) Dips 2.43% as Stock Approaches Key Support Level - Sweep Order Flow dars.gov.et Tue, 07 Jul 2026 17:38:30 GMT
• Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the... The Manila Times Tue, 07 Jul 2026 11:43:31 GMT
• Acumen to show brain-delivery data and patient insights at AAIC 2026 Stock Titan Tue, 07 Jul 2026 11:30:00 GMT
• Number of shareholders of Acumen Pharmaceuticals, Inc. – NASDAQ:ABOS TradingView Fri, 03 Jul 2026 13:04:22 GMT
• Acumen Pharmaceuticals, Inc. commits to advancing targeted therapies for Alzheimer care Traders Union Tue, 30 Jun 2026 13:40:27 GMT
• acumen pharmaceuticals, inc.(nasdaqgs: abos) added to russell 2000 index marketscreener.com Mon, 29 Jun 2026 21:43:27 GMT
• Acumen Pharmaceuticals, Inc.(NasdaqGS: ABOS) added to Russell 2500 Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• Acumen Pharmaceuticals, Inc.(NasdaqGS:ABOS) added to Russell Small Cap Completeness Index marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• ABOS Q1 2026 Earnings: EPS Beat Strong as Acumen Advances Alzheimer’s Pipeline - Revenue Recognition Risk dars.gov.et Sun, 28 Jun 2026 07:00:00 GMT
• Acumen Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:ABOS) TradingView Thu, 25 Jun 2026 23:33:37 GMT
• acumen pharmaceuticals inc (abos) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• Acumen Pharmaceuticals (ABOS) Holds Steady Near $2.26 as Biotech Sector Watches for Next Move - Bearish Pattern Stocks dars.gov.et Sat, 20 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals inc (abos) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 09:30:11 GMT
• JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for... BioSpace Thu, 18 Jun 2026 07:00:00 GMT
• Acumen Pharmaceuticals Inc (ABOS) Financial Health: Profitability & Balance Sheet Analysis TradingKey Thu, 18 Jun 2026 05:44:16 GMT
• acumen pharmaceuticals insider makes eye-catching stock move TipRanks Thu, 18 Jun 2026 02:30:22 GMT
• acumen pharmaceuticals director porter sells $75,239 in stock by investing.com Investing.com India Wed, 17 Jun 2026 23:06:49 GMT
• Acumen Pharmaceuticals Inc (ABOS) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Wed, 17 Jun 2026 22:53:43 GMT
• acumen pharmaceuticals inc (abos) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 21:27:39 GMT
• acumen pharmaceuticals inc (abos) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 20:58:38 GMT
• acumen pharmaceuticals inc (abos) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 20:53:37 GMT
• acumen pharmaceuticals inc (abos) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 20:53:33 GMT
• Acumen Pharmaceuticals Inc (ABOS) Institutional Confidence TradingKey Wed, 17 Jun 2026 20:47:24 GMT
• jcr announces acumen exercises exclusive option for alzheimer’s candidates TipRanks Wed, 17 Jun 2026 19:16:24 GMT
• jcr pharmaceuticals announces that acumen pharmaceuticals has exercised its exclusive option to develop therapeutic candidates for... Business Wire Wed, 17 Jun 2026 16:30:00 GMT
• Acumen selects development candidates for Alzheimer’s disease BioWorld News Wed, 17 Jun 2026 13:00:00 GMT
• Acumen Pharmaceuticals (ABOS) director sells 32,300 shares after exercising options Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• Director to sell 13,040 shares (NASDAQ: ABOS) in stock option exercise Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• acumen nominates two alzheimer’s candidates for development by investing.com Investing.com South Africa Wed, 17 Jun 2026 01:47:04 GMT
• Acumen Pharmaceuticals Nominates Two Development Candidates in Enhanced Brain Delivery Program for Alzheimer's Disease Treatment Quiver Quantitative Tue, 16 Jun 2026 07:00:00 GMT
• Two new antibody designs aim for higher brain delivery in Alzheimer’s Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Acumen Nominates 2 Therapies to Treat Alzheimer’s Disease Yahoo Finance Tue, 16 Jun 2026 07:00:00 GMT
• Acumen (NASDAQ: ABOS) advances two EBD Alzheimer’s drug candidates Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• ABOS (NASDAQ: ABOS) Form 144 shows proposed sale of 12,800 shares Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alz... The Manila Times Tue, 16 Jun 2026 07:00:00 GMT
• Acumen Advances Enhanced Brain Delivery Alzheimer’s Drug Candidates TipRanks Tue, 16 Jun 2026 07:00:00 GMT
• Acumen Pharmaceuticals, Inc. advances two new Enhanced Brain Delivery candidates for Alzheimer treatment Traders Union Tue, 16 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals nominates two ebd candidates, targets mid-2027 ind with 14-40x brain penetration in nhps TradingView Tue, 16 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals inc (abos) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals inc (abos) institutional confidence TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals inc (abos) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• Acumen Pharmaceuticals Slides 1.27% as Alzheimer’s Stock Tests Key Support at $2.22 - Bollinger Squeeze dars.gov.et Mon, 15 Jun 2026 07:00:00 GMT
• bofa securities maintains acumen pharmaceuticals(abos.us) with buy rating, maintains target price $8 Moomoo Thu, 11 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals director sells $14,272 in company stock Investing.com Thu, 11 Jun 2026 00:59:50 GMT
• insider sell: nathan fountain sells 6,400 shares of acumen pharm GuruFocus Wed, 10 Jun 2026 22:22:22 GMT
• acumen pharmaceuticals director sells $14,272 in company stock Investing.com Wed, 10 Jun 2026 07:00:00 GMT
• major insider move at acumen pharmaceuticals shakes up investor sentiment TipRanks Wed, 10 Jun 2026 07:00:00 GMT
• director nathan fountain sells 6,400 acumen (abos) shares at ~$2.23 Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals | 4: statement of changes in beneficial ownership of securities-director fountain nathan b Moomoo Wed, 10 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals | 144: notice of proposed sale of securities pursuant to rule 144 Moomoo Tue, 09 Jun 2026 07:00:00 GMT
• abos q1 2026 earnings: narrower-than-expected loss as phase 2 readout approaches - downward estimate revision newsline.com Sat, 06 Jun 2026 05:44:40 GMT
• Acumen Pharmaceuticals (ABOS) director receives RSU and option grants Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals (abos) director awarded rsus and options for ra capital Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals (abos) grants rsus and stock options to director Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals (abos) director receives new rsu and option awards Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals (nasdaq: abos) director awarded rsus and options Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals (nasdaq: abos) director receives rsu and option grants Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• acumen (nasdaq: abos) director granted rsus and options vesting by 2027 Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• acumen (nasdaq: abos) director equity grant tied to ra capital funds Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• Acumen Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $7.4, Implies 212% Upside TradingView Wed, 03 Jun 2026 07:00:00 GMT
• Acumen Stockholders Approve Directors and Equity Incentive Plan TipRanks Wed, 03 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals (nasdaq: abos) investors approve equity plan and auditor Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals (abos) q1 2026 earnings: narrower loss per share as clinical pipeline advances - analyst coverage count newsline.com Wed, 03 Jun 2026 07:00:00 GMT
• acumen pharmaceuticals, inc. pushes research for brain health as dementia numbers climb Traders Union Tue, 02 Jun 2026 12:55:16 GMT
• Acumen Pharmaceuticals (ABOS) Holds Near Key Support After Slight Upside Move - Stop Loss Guidance dars.gov.et Sat, 30 May 2026 07:00:00 GMT
• is acumen pharmaceuticals (abos) stock outpacing its medical peers this year? MSN Fri, 29 May 2026 18:03:32 GMT
• acumen pharmaceuticals (abos) gains nearly 5% as stock tests resistance at $2.67 - break of structure The Legal Advocate Thu, 28 May 2026 00:40:46 GMT
• acumen pharmaceuticals (abos) gains nearly 5% as stock tests resistance at $2.67 - bpi reversal newsline.com Wed, 27 May 2026 07:00:00 GMT
• acumen pharmaceuticals (abos) slides 3.59%, testing near-term support - hot stock picks newsline.com Tue, 26 May 2026 07:00:00 GMT
• b of a securities maintains acumen pharmaceuticals (abos) buy recommendation MSN Tue, 26 May 2026 05:18:11 GMT
• acumen pharmaceuticals (abos) edges higher amid low volume, tests key resistance levels - straddle setup The Legal Advocate Tue, 26 May 2026 00:46:08 GMT
• acumen pharmaceuticals (abos) holds ground near resistance: can biotech momentum continue? - profitability factor newsline.com Mon, 25 May 2026 07:00:00 GMT
• acumen pharmaceuticals (abos) price target decreased by 20.59% to 6.88 MSN Sun, 24 May 2026 01:36:45 GMT
• acumen pharmaceuticals q1 2026 earnings: narrowed loss surprises as alzheimer’s pipeline advances - gaap earnings report The Legal Advocate Fri, 22 May 2026 03:31:44 GMT
• acumen pharmaceuticals (abos) gains momentum: support holds at $2.37, resistance at $2.61 in focus - value area high Newser Thu, 21 May 2026 23:30:30 GMT
• acumen pharmaceuticals q1 2026 earnings: narrowed loss surprises as alzheimer’s pipeline advances - analyst drop coverage newsline.com Thu, 21 May 2026 07:00:00 GMT
• Acumen’s Late-2026 Sabirnetug Readout Is A Viable Bet (NASDAQ:ABOS) Seeking Alpha Wed, 20 May 2026 07:00:00 GMT
• bank of america securities remains a buy on acumen pharmaceuticals (abos) The Globe and Mail Sat, 16 May 2026 10:00:00 GMT
• bofa securities maintains acumen pharmaceuticals(abos.us) with buy rating, maintains target price $8 Moomoo Fri, 15 May 2026 16:01:05 GMT
• earnings call transcript: acumen pharmaceuticals beats q1 2026 eps forecast Investing.com Fri, 15 May 2026 07:00:00 GMT
• acumen pharmaceuticals (abos) loses 33.6% in 4 weeks, here's why a trend reversal may be around the corner MSN Fri, 15 May 2026 04:04:28 GMT
• acumen pharmaceuticals warns investors: unchanged 10-k risk factors still weigh on valuation and share price TipRanks Thu, 14 May 2026 06:39:19 GMT
• acumen pharmaceuticals reports q1 2026 results: full earnings call transcript Sahm Wed, 13 May 2026 14:37:43 GMT
• acumen pharmaceuticals, inc. (nasdaq:abos) q1 2026 earnings call transcript Insider Monkey Wed, 13 May 2026 12:29:36 GMT
• acumen pharmaceuticals warns investors: unchanged 10-k risk factors still weigh on valuation and share price TipRanks Wed, 13 May 2026 07:00:00 GMT
• acumen updates q1 results and alzheimer’s pipeline progress The Globe and Mail Wed, 13 May 2026 07:00:00 GMT
• [10-q] acumen pharmaceuticals, inc. quarterly earnings report Stock Titan Tue, 12 May 2026 21:19:46 GMT
• acumen pharmaceuticals, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Tue, 12 May 2026 21:16:00 GMT
• acumen expects altitude-ad top-line results in late 2026 while targeting a mid-2027 ind for 2 ebd candidates MSN Tue, 12 May 2026 17:33:17 GMT
• acumen pharmaceuticals, inc. posts first quarter financial results and reports business momentum Traders Union Tue, 12 May 2026 15:25:54 GMT
• abos: phase ii alzheimer's trial on track, ebd program advances, $128.4m cash supports runway into 2027 TradingView Tue, 12 May 2026 13:16:55 GMT
• acumen pharmaceuticals (nasdaq:abos) q1 2026 loss narrows as phase 2 alzheimer's trial readout looms ChartMill Tue, 12 May 2026 12:23:10 GMT
• Acumen Pharmaceuticals Provides Business Update and Financial Results Highlighting Phase 2 Study Progress for Alzheimer’s Treatmen... Quiver Quantitative Tue, 12 May 2026 07:00:00 GMT
• alzheimer’s trial data slated for late 2026 as acumen holds $128m cash Stock Titan Tue, 12 May 2026 07:00:00 GMT
• acumen pharmaceuticals reports first quarter 2026 financial results and business highlights The Manila Times Tue, 12 May 2026 07:00:00 GMT
• acumen pharmaceuticals inc (abos) q1 2026 earnings call highlights: strategic advances amid ... by gurufocus Investing.com Canada Tue, 12 May 2026 07:00:00 GMT
• acumen pharmaceuticals reports q1 2026 results: full earnings call transcript Benzinga Tue, 12 May 2026 07:00:00 GMT
• acumen updates q1 results and alzheimer’s pipeline progress TipRanks Tue, 12 May 2026 07:00:00 GMT
• acumen pharmaceuticals 1q 2026: net loss $(20.7)m, eps $(0.33) — 10-q summary TradingView Tue, 12 May 2026 07:00:00 GMT
• acumen pharmaceuticals ($abos) releases q1 2026 earnings Quiver Quantitative Tue, 12 May 2026 07:00:00 GMT
• acumen pharmaceuticals (nasdaq: abos) posts q1 2026 loss but extends cash runway Stock Titan Tue, 12 May 2026 07:00:00 GMT
• acumen pharmaceuticals reports q1 2026 financial results and anticipates phase 2 altitude-ad data for alzheimer’s treatment Minichart Tue, 12 May 2026 07:00:00 GMT
• exclusive bac article: acumen pharmaceuticals; late 2026 sabirnetug ad data, ebd program candidate ind filing mid-2027 and catalys... Seeking Alpha Tue, 12 May 2026 07:00:00 GMT
• acumen (nasdaq: abos) trims q1 loss but warns on going concern Stock Titan Tue, 12 May 2026 07:00:00 GMT
• earnings call transcript: acumen pharmaceuticals q1 2026 results show eps beat Investing.com Tue, 12 May 2026 07:00:00 GMT
• is acumen pharmaceuticals (abos) stock outpacing its medical peers this year? MSN Mon, 11 May 2026 09:04:06 GMT
• acumen pharmaceuticals (abos) loses 33.6% in 4 weeks, here's why a trend reversal may be around the corner MSN Sun, 10 May 2026 11:41:43 GMT
• Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference The Manila Times Fri, 08 May 2026 07:00:00 GMT
• acumen pharmaceuticals inc expected to post a loss of 40 cents a share - earnings preview TradingView Fri, 08 May 2026 07:00:00 GMT
• acumen pharmaceuticals to participate in the bank of america securities 2026 health care conference marketscreener.com Thu, 07 May 2026 20:00:05 GMT
• acumen pharmaceuticals (abos.us) is scheduled to release its earnings report before the market opens on may 12. 富途牛牛 Thu, 07 May 2026 11:23:43 GMT
• Acumen executives take Bank of America health care stage May 14 Stock Titan Thu, 07 May 2026 07:00:00 GMT
• acumen pharmaceuticals to present at bank of america 2026 health care conference on may 14. Pluang Thu, 07 May 2026 07:00:00 GMT
• acumen pharmaceuticals (abos.us) will release its earnings report before the market opens on may 12. Moomoo Thu, 07 May 2026 02:19:20 GMT
• how acumen (abos) responds to market challenges (breakout watch) 2026-05-06 - fade trade Newser Wed, 06 May 2026 07:00:00 GMT
• acumen pharmaceuticals to report first quarter financial results on may 12, 2026 富途牛牛 Tue, 05 May 2026 20:00:00 GMT
• acumen pharmaceuticals to report q1 2026 financial results on may 12 with a live webcast. Pluang Tue, 05 May 2026 07:00:00 GMT
• acumen sets may 12 earnings update, webcast starts at 8 a.m. et Stock Titan Tue, 05 May 2026 07:00:00 GMT
• abos forecast, price target & analyst ratings | acumen pharmaceuticals inc (nasdaq:abos) ChartMill Fri, 01 May 2026 07:00:00 GMT
• short interest in acumen pharmaceuticals, inc. (nasdaq:abos) increases by 46.4% MarketBeat Tue, 28 Apr 2026 05:38:53 GMT
• is acumen pharmaceuticals (abos) stock outpacing its medical peers this year? MSN Mon, 27 Apr 2026 17:56:41 GMT
• acumen pharmaceuticals files to sell 10.83m shares of common stock for holders MSN Sun, 26 Apr 2026 11:47:55 GMT
• acumen pharmaceuticals files to sell 10.83m shares of common stock for holders MSN Sat, 25 Apr 2026 10:15:49 GMT
• research presented by acumen pharmaceuticals explores new approach at aan meeting Traders Union Fri, 24 Apr 2026 21:40:15 GMT
• abos forecast, price target & analyst ratings | acumen pharmaceuticals inc (nasdaq:abos) ChartMill Fri, 24 Apr 2026 07:00:00 GMT
• acumen pharmaceuticals files to sell 10.83m shares of common stock for holders MSN Fri, 24 Apr 2026 04:08:38 GMT
• acumen targets altitude-ad phase ii readout in late 2026 while advancing ebd program with $36m funding MSN Fri, 24 Apr 2026 02:41:23 GMT
Acumen Pharmaceuticals Inc(NASDAQ:ABOS) 
Share this website to your friends